AbCellera Biologics Inc logo

AbCellera Biologics Inc Investor Relations Material

AbCellera Biologics, Inc. operates as a biotechnology company. The Company offers antibody discovery platform that accelerates the design of therapeutic antibodies and helps researchers discover new treatments for people with cancer or Alzheimer's disease. The company's platform discovers and characterizes fully human antibodies from natural immune responses in order to provide insights into how best to stimulate the human immune system

Upcoming events for

Q4 20222023-02-23

Latest company events

Ticker symbol

ABCL

Country

United States of America

Dig deeper into the AbCellera Biologics Inc fundamentals on Quartr.

  • Conference calls from all over the world
  • Search for anything across all transcripts
  • Consensus estimates
  • Comprehensive financial data
  • Read the transcripts or scroll the deck
  • Slide decks and earnings reports
App store link
Android play link
Quartr app screenshot